Cargando…
Understanding endocrine resistance: the critical need for sequential samples from clinical breast cancer and novel in vitro models
Autores principales: | Gee, Julia MW, Hutcheson, Iain R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1242147/ https://www.ncbi.nlm.nih.gov/pubmed/16168136 http://dx.doi.org/10.1186/bcr1289 |
Ejemplares similares
-
Cannibalism, cell survival, and endocrine resistance in breast cancer
por: Clarke, Robert
Publicado: (2011) -
Impact of dual mTORC1/2 mTOR kinase inhibitor AZD8055 on acquired endocrine resistance in breast cancer in vitro
por: Jordan, Nicola J, et al.
Publicado: (2014) -
Extreme growth factor signalling can promote oestrogen receptor-α loss: therapeutic implications in breast cancer
por: Gee, Julia MW, et al.
Publicado: (2004) -
Chaperone-mediated destruction of erbB2: relevance to tyrosine kinase inhibitors
por: Gee, Julia MW
Publicado: (2002) -
ADAM metalloproteases and EGFR signalling
por: Gee, Julia MW, et al.
Publicado: (2003)